Climate change, urbanization and drug resistance are creating optimal conditions for typhoid to spread. Tracking the disease can be challenging, especially for rural and under-resourced communities. The primary diagnostic test — a blood culture — requires special laboratory facilities to process.
But there is hope. For the first time, infants and young children, who experience the greatest impact of typhoid, are eligible for typhoid vaccines.
We work to ensure that countries where typhoid is common have the data they need to make strategic decisions about introducing the new typhoid conjugate vaccines. We also partner with scientists and health workers to advance a holistic approach that includes vaccines and WASH (water, sanitation and hygiene) strategies.
11-21MAn estimated 11-21 million cases of typhoid fever occur globally each year. (WHO, 2018)
200,000Approximately 200,000 deaths occur globally each year from typhoid. (CDC, 2021)
75%Around 75 percent of typhoid deaths occur in Asia. (Global Burden of Disease, 2017)
Research for Locally Led Solutions
Our surveillance studies track and measure the spread of typhoid on communities in South Asia and provide insights for vaccine roll out.
Partnerships to Prevent Typhoid
The Coalition against Typhoid unites scientists, health workers and policy makers in advancing sustainable methods to end typhoid.
We make vaccines more accessible, enable innovation and expand immunization across the globe.